Company: PTPI
Filing Date: 2025-02-14
Form Type: CORRESP
Source: 0001104659-25-013913
Chunk: 0

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: CORRESP
Chunk 0
---
<div align='center'>Petros Pharmaceuticals, Inc.

1185 Avenue of the Americas, 3rd Floor

New York, New York 10036</div>

February 14, 2025

| VIA EDGAR                               |
| Division of Corporation Finance         |
| Office of Life Sciences                 |
| U.S. Securities and Exchange Commission |
| Washington, D.C. 20549                  |
| Attention: Daniel Crawford              |

| Re: | Petros Pharmaceuticals, Inc.                                   
 Amendment No. 3 to Registration Statement on Form S-1          
 Filed on February 14, 2025                                     
 File No. 333-284495 (as amended, the “Registration Statement”) 
 Request for Acceleration                                       |

Ladies and Gentlemen:

Pursuant to Rule 461 of the
Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act
of 1933, as amended, Petros Pharmaceuticals, Inc. (the “Company”), hereby respectfully requests acceleration
of the effective date of the Registration Statement, so that it may become effective at 4:00 p.m., Eastern Time, on February 14, 2025,
or as soon thereafter as practicable.

Should any member of the staff
of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention:
Alla Digilova, Esq. at (212) 659-4993.

| Very truly yours,            |                                        |
| PEtros Pharmaceuticals, Inc. |                                        |
| By:                          | /s/ Fady Boctor                        |
|                              | Fady Boctor                            |
|                              | President and Chief Commercial Officer |

| cc: | Alla Digilova, Esq., Haynes and Boone, LLP |